BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36000310)

  • 21. γδ T cell responses: How many ligands will it take till we know?
    Vermijlen D; Gatti D; Kouzeli A; Rus T; Eberl M
    Semin Cell Dev Biol; 2018 Dec; 84():75-86. PubMed ID: 29402644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.
    Chitadze G; Oberg HH; Wesch D; Kabelitz D
    Trends Immunol; 2017 Sep; 38(9):668-678. PubMed ID: 28709825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current progress in γδ T-cell biology.
    Hao J; Wu X; Xia S; Li Z; Wen T; Zhao N; Wu Z; Wang P; Zhao L; Yin Z
    Cell Mol Immunol; 2010 Nov; 7(6):409-13. PubMed ID: 21042298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy.
    Lee D; Rosenthal CJ; Penn NE; Dunn ZS; Zhou Y; Yang L
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
    Paul S; Lal G
    Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling of the early transcriptional response of murine gammadelta T cells following TCR stimulation.
    Laird RM; Hayes SM
    Mol Immunol; 2009 Jul; 46(11-12):2429-38. PubMed ID: 19439358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
    Saura-Esteller J; de Jong M; King LA; Ensing E; Winograd B; de Gruijl TD; Parren PWHI; van der Vliet HJ
    Front Immunol; 2022; 13():915837. PubMed ID: 35784326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Our evolving understanding of the role of the γδ T cell receptor in γδ T cell mediated immunity.
    Gully BS; Rossjohn J; Davey MS
    Biochem Soc Trans; 2021 Nov; 49(5):1985-1995. PubMed ID: 34515758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy.
    Papadakos SP; Arvanitakis K; Stergiou IE; Koutsompina ML; Germanidis G; Theocharis S
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer immunotherapy harnessing γδ T cells and programmed death-1.
    Tanaka Y
    Immunol Rev; 2020 Nov; 298(1):237-253. PubMed ID: 32888218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. γδ T cells in artiodactyls: Focus on swine.
    Le Page L; Baldwin CL; Telfer JC
    Dev Comp Immunol; 2022 Mar; 128():104334. PubMed ID: 34919982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering γδ T Cells: Recognizing and Activating on Their Own Way.
    Dong R; Zhang Y; Xiao H; Zeng X
    Front Immunol; 2022; 13():889051. PubMed ID: 35603176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.
    Brandes M; Willimann K; Bioley G; Lévy N; Eberl M; Luo M; Tampé R; Lévy F; Romero P; Moser B
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2307-12. PubMed ID: 19171897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. γδ T cells in oral diseases.
    Wei XY; Tan YQ; Zhou G
    Inflamm Res; 2024 May; 73(5):867-876. PubMed ID: 38563967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cytokine producing activity of intestinal intraepithelial T cells from TCR beta-chain and delta-chain mutant mice.
    Kohyama M; Hachimura S; Nanno M; Ishikawa H; Kaminogawa S
    Microbiol Immunol; 1997; 41(4):353-9. PubMed ID: 9159410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. γδ T cells: The potential role in liver disease and implications for cancer immunotherapy.
    Ren H; Li W; Liu X; Zhao N
    J Leukoc Biol; 2022 Dec; 112(6):1663-1668. PubMed ID: 36098208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
    Yakou MH; Ghilas S; Tran K; Liao Y; Afshar-Sterle S; Kumari A; Schmid K; Dijkstra C; Inguanti C; Ostrouska S; Wilcox J; Smith M; Parathan P; Allam A; Xue HH; Belz GT; Mariadason JM; Behren A; Drummond GR; Ruscher R; Williams DS; Pal B; Shi W; Ernst M; Raghu D; Mielke LA
    Sci Immunol; 2023 Oct; 8(88):eadf2163. PubMed ID: 37801516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative view on vitamin C effects on αβ- versus γδ T-cell activation and differentiation.
    Peters C; Kouakanou L; Kabelitz D
    J Leukoc Biol; 2020 Jun; 107(6):1009-1022. PubMed ID: 32034803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.